Connective tissue disease-related interstitial lung disease.

[1]  Jonathan H. Chung,et al.  Predictors of mortality in rheumatoid arthritis-associated interstitial lung disease , 2015, European Respiratory Journal.

[2]  J. Leipsic,et al.  Predicting Mortality in Systemic Sclerosis-Associated Interstitial Lung Disease Using Risk Prediction Models Derived From Idiopathic Pulmonary Fibrosis. , 2015, Chest.

[3]  Meng Wang,et al.  Pulmonary hypertension in polymyositis , 2015, Clinical Rheumatology.

[4]  R. Speich,et al.  Pulmonary Function Tests: High Rate of False Negatives in the Early Detection and Screening of Scleroderma Interstitial Lung Disease , 2015 .

[5]  D. Lynch,et al.  An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features , 2015, European Respiratory Journal.

[6]  M. Glassberg,et al.  Pulmonary complications of inflammatory myopathy. , 2015, Rheumatic diseases clinics of North America.

[7]  G. de Luca,et al.  Long-term efficacy of B cell depletion therapy on lung and skin involvement in diffuse systemic sclerosis. , 2015, Seminars in arthritis and rheumatism.

[8]  G. Verleden,et al.  Is lung transplantation a valuable therapeutic option for patients with pulmonary polymyositis? Experiences from the Leuven transplant cohort. , 2014, Transplantation proceedings.

[9]  X. Corbella,et al.  Mortality and survival in systemic sclerosis: systematic review and meta-analysis. , 2014, Seminars in arthritis and rheumatism.

[10]  A. Young,et al.  Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics--a large multicentre UK study. , 2014, Rheumatology.

[11]  A. Fischer,et al.  The lung may play a role in the pathogenesis of rheumatoid arthritis. , 2014, International journal of clinical rheumatology.

[12]  D. Hashimoto,et al.  Prognostic Factors for Myositis-Associated Interstitial Lung Disease , 2014, PloS one.

[13]  R. Sussman,et al.  A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. , 2014, The New England journal of medicine.

[14]  H. Collard,et al.  Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. , 2014, The New England journal of medicine.

[15]  R. Zubarev,et al.  Shared immunological targets in the lungs and joints of patients with rheumatoid arthritis: identification and validation , 2014, Annals of the rheumatic diseases.

[16]  V. Strand,et al.  Survival and quality of life in rheumatoid arthritis-associated interstitial lung disease after lung transplantation. , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[17]  Joyce S Lee,et al.  Predicting survival across chronic interstitial lung disease: the ILD-GAP model. , 2014, Chest.

[18]  F. Bonella,et al.  Biomarkers in Connective Tissue Disease-Associated Interstitial Lung Disease , 2014, Seminars in Respiratory and Critical Care Medicine.

[19]  S. Danoff,et al.  Pulmonary Manifestations of Polymyositis/Dermatomyositis , 2014, Seminars in Respiratory and Critical Care Medicine.

[20]  L. Klareskog,et al.  Structural Changes and Antibody Enrichment in the Lungs Are Early Features of Anti–Citrullinated Protein Antibody–Positive Rheumatoid Arthritis , 2014, Arthritis & rheumatology.

[21]  D. Ross,et al.  Lung transplantation in patients with scleroderma , 2013, Current opinion in rheumatology.

[22]  H. Collard,et al.  Rheumatoid arthritis-associated interstitial lung disease: radiologic identification of usual interstitial pneumonia pattern. , 2013, Radiology.

[23]  J. Norris,et al.  Sputum autoantibodies in patients with established rheumatoid arthritis and subjects at risk of future clinically apparent disease. , 2013, Arthritis and rheumatism.

[24]  T. Fukuda,et al.  Marked increase in serum KL-6 and surfactant protein D levels during the first 4 weeks after treatment predicts poor prognosis in patients with active interstitial pneumonia associated with polymyositis/dermatomyositis , 2013, Modern rheumatology.

[25]  J. Myers,et al.  Fibrosing interstitial pneumonia predicts survival in patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD). , 2013, Respiratory medicine.

[26]  R. Winchester,et al.  Association of fine specificity and repertoire expansion of anticitrullinated peptide antibodies with rheumatoid arthritis associated interstitial lung disease , 2013, Annals of the rheumatic diseases.

[27]  R. D. du Bois,et al.  Mycophenolate Mofetil Improves Lung Function in Connective Tissue Disease-associated Interstitial Lung Disease , 2013, The Journal of Rheumatology.

[28]  Lisa Harlow,et al.  Identification of citrullinated hsp90 isoforms as novel autoantigens in rheumatoid arthritis-associated interstitial lung disease. , 2013, Arthritis and rheumatism.

[29]  M. Sugimoto,et al.  Pneumocystis jirovecii infection: an emerging threat to patients with rheumatoid arthritis , 2012, Rheumatology.

[30]  T. Hartman,et al.  Open-Label, Pilot Study of the Safety and Clinical Effects of Rituximab in Patients with Rheumatoid Arthritis-Associated Interstitial Pneumonia , 2012 .

[31]  D. Lynch,et al.  Lung disease with anti-CCP antibodies but not rheumatoid arthritis or connective tissue disease. , 2012, Respiratory medicine.

[32]  K. Anstrom,et al.  A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis. , 2012, American journal of respiratory and critical care medicine.

[33]  A. Orbai,et al.  A Novel Dermato-Pulmonary Syndrome Associated With MDA-5 Antibodies: Report of 2 Cases and Review of the Literature , 2012, Medicine.

[34]  D. Lynch,et al.  Brief report: airways abnormalities and rheumatoid arthritis-related autoantibodies in subjects without arthritis: early injury or initiating site of autoimmunity? , 2012, Arthritis and rheumatism.

[35]  Kevin J Anstrom,et al.  Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. , 2012, The New England journal of medicine.

[36]  J. Ménard,et al.  Rituximab therapy for refractory interstitial lung disease related to antisynthetase syndrome. , 2012, Respiratory medicine.

[37]  K. Brown,et al.  Rheumatoid arthritis-associated interstitial lung disease , 2012, Open access rheumatology : research and reviews.

[38]  G. Raghu,et al.  Silent gastro-oesophageal reflux and microaspiration in IPF: mounting evidence for anti-reflux therapy? , 2012, European Respiratory Journal.

[39]  L. Mouthon,et al.  Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis: a series of 107 patients. , 2011, Arthritis and rheumatism.

[40]  Chi-Hong Tseng,et al.  Clinical course of lung physiology in patients with scleroderma and interstitial lung disease: analysis of the Scleroderma Lung Study Placebo Group. , 2011, Arthritis and rheumatism.

[41]  E. Hachulla,et al.  Infectious complications in polymyositis and dermatomyositis: a series of 279 patients. , 2011, Seminars in arthritis and rheumatism.

[42]  F. Castelino,et al.  The impact of rheumatological evaluation in the management of patients with interstitial lung disease. , 2011, Rheumatology.

[43]  G. Raghu,et al.  Rheumatoid arthritis-interstitial lung disease-associated mortality. , 2011, American journal of respiratory and critical care medicine.

[44]  N. Takayanagi,et al.  Lung diseases directly associated with rheumatoid arthritis and their relationship to outcome , 2010, European Respiratory Journal.

[45]  S. West,et al.  Connective tissue disease-associated interstitial lung disease: a call for clarification. , 2010, Chest.

[46]  D. Pappas,et al.  Respiratory symptoms and disease characteristics as predictors of pulmonary function abnormalities in patients with rheumatoid arthritis: an observational cohort study , 2010, Arthritis research & therapy.

[47]  T. E. King,et al.  Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease , 2009, European Respiratory Journal.

[48]  H. Collard,et al.  Rheumatoid arthritis-associated interstitial lung disease: the relevance of histopathologic and radiographic pattern. , 2009, Chest.

[49]  J. Gran,et al.  Rituximab treatment of the anti-synthetase syndrome: a retrospective case series. , 2009, Rheumatology.

[50]  M. Strek,et al.  Clinical Characteristics of Patients With Anti-Jo-1 Antibodies: A Single Center Experience , 2009, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[51]  R. Domsic,et al.  Anti-U11/U12 RNP antibodies in systemic sclerosis: a new serologic marker associated with pulmonary fibrosis. , 2009, Arthritis and rheumatism.

[52]  T. Colby,et al.  Pathologic and radiologic differences between idiopathic and collagen vascular disease-related usual interstitial pneumonia. , 2009, Chest.

[53]  S. Sahn,et al.  Clinical profile of anti-PL-12 autoantibody. Cohort study and review of the literature. , 2009, Chest.

[54]  D. Lynch,et al.  Computed Tomographic Features of Idiopathic Fibrosing Interstitial Pneumonia: Comparison With Pulmonary Fibrosis Related to Collagen Vascular Disease , 2009, Journal of computer assisted tomography.

[55]  K. Chida,et al.  Intravenous Immunoglobulin Therapy for Refractory Interstitial Lung Disease Associated with Polymyositis/Dermatomyositis , 2009, Lung.

[56]  K. Brown,et al.  Rheumatoid arthritis (RA)-specific autoantibodies in patients with interstitial lung disease and absence of clinically apparent articular RA , 2009, Clinical Rheumatology.

[57]  S. Luo,et al.  Interstitial lung disease in polymyositis and dermatomyositis , 2009, Clinical Rheumatology.

[58]  P. Ravaud,et al.  Pneumomediastinum in interstitial lung disease associated with dermatomyositis and polymyositis. , 2008, Arthritis and rheumatism.

[59]  Jonathan G Goldin,et al.  High-resolution CT scan findings in patients with symptomatic scleroderma-related interstitial lung disease. , 2008, Chest.

[60]  D. Hansell,et al.  Interstitial lung disease in systemic sclerosis: a simple staging system. , 2008, American journal of respiratory and critical care medicine.

[61]  H. Collard,et al.  Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease? , 2007, American journal of respiratory and critical care medicine.

[62]  K. Leslie,et al.  Pulmonary pathology of the rheumatic diseases. , 2007, Seminars in respiratory and critical care medicine.

[63]  A. Nicholson,et al.  Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes. , 2007, American journal of respiratory and critical care medicine.

[64]  N. Goel,et al.  Pulmonary involvement in systemic sclerosis: associations with genetic, serologic, sociodemographic, and behavioral factors. , 2007, Arthritis and rheumatism.

[65]  T. Medsger,et al.  Changes in causes of death in systemic sclerosis, 1972–2002 , 2007, Annals of the rheumatic diseases.

[66]  Y. Alamanos,et al.  Pulmonary involvement in patients with early rheumatoid arthritis , 2007, Scandinavian journal of rheumatology.

[67]  M. Gaxiola,et al.  Inducible bronchus-associated lymphoid tissue (iBALT) in patients with pulmonary complications of rheumatoid arthritis. , 2006, The Journal of clinical investigation.

[68]  Rebecca M. Lindell,et al.  Interstitial lung disease in primary Sjögren syndrome. , 2006, Chest.

[69]  M. Remy-Jardin,et al.  High resolution computed tomography in fibrosing alveolitis associated with systemic sclerosis. , 2006, The Journal of rheumatology.

[70]  Charlie Strange,et al.  Cyclophosphamide versus placebo in scleroderma lung disease. , 2006, The New England journal of medicine.

[71]  N. Müller,et al.  Drug-induced lung diseases: most common reaction patterns and corresponding high-resolution CT manifestations. , 2006, Seminars in ultrasound, CT, and MR.

[72]  J. Seo,et al.  Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease. , 2005, Chest.

[73]  A. Nicholson,et al.  Pulmonary manifestations of primary Sjogren's syndrome: a clinical, radiologic, and pathologic study. , 2005, American journal of respiratory and critical care medicine.

[74]  N. Miyasaka,et al.  Polymyositis/dermatomyositis and interstitial lung disease: A new therapeutic approach with T-cell-specific immunosuppressants , 2005, Autoimmunity.

[75]  T. Igishi,et al.  Role of KL-6 in evaluating the disease severity of rheumatoid lung disease: comparison with HRCT. , 2004, Respiratory medicine.

[76]  P. Laippala,et al.  Death rates and causes of death in patients with rheumatoid arthritis: a population‐based study , 2004, Scandinavian journal of rheumatology.

[77]  A. Nicholson,et al.  Variations in histological patterns of interstitial pneumonia between connective tissue disorders and their relationship to prognosis , 2004, Histopathology.

[78]  Shinichi Sato,et al.  Comparative study of serum surfactant protein-D and KL-6 concentrations in patients with systemic sclerosis as markers for monitoring the activity of pulmonary fibrosis. , 2004, The Journal of rheumatology.

[79]  I. Lundberg,et al.  Interstitial lung disease, a common manifestation of newly diagnosed polymyositis and dermatomyositis , 2004, Annals of the rheumatic diseases.

[80]  V. Cottin,et al.  Interstitial lung disease in amyopathic dermatomyositis, dermatomyositis and polymyositis , 2003, European Respiratory Journal.

[81]  S. Gabriel,et al.  Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years , 2003, Annals of the rheumatic diseases.

[82]  F. Martinez,et al.  Fibroblastic foci in usual interstitial pneumonia: idiopathic versus collagen vascular disease. , 2003, American journal of respiratory and critical care medicine.

[83]  Y. Nakajima,et al.  Nonspecific interstitial pneumonia associated with polymyositis and dermatomyositis: serial high-resolution CT findings and functional correlation. , 2003, Chest.

[84]  E. Hachulla,et al.  Interstitial lung disease in polymyositis and dermatomyositis. , 2002, Arthritis and rheumatism.

[85]  A. Nicholson,et al.  Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. , 2002, American journal of respiratory and critical care medicine.

[86]  D. Schroeder,et al.  Polymyositis-dermatomyositis-associated interstitial lung disease. , 2001, American journal of respiratory and critical care medicine.

[87]  J. Dawson,et al.  Fibrosing alveolitis in patients with rheumatoid arthritis as assessed by high resolution computed tomography, chest radiography, and pulmonary function tests , 2001, Thorax.

[88]  P. Ducrotte,et al.  Esophageal involvement and pulmonary manifestations in systemic sclerosis. , 2001, Arthritis and rheumatism.

[89]  N. Kohno,et al.  Sequential changes of KL-6 in sera of patients with interstitial pneumonia associated with polymyositis/dermatomyositis , 2000, Annals of the rheumatic diseases.

[90]  C. Turesson,et al.  Extra-articular rheumatoid arthritis: prevalence and mortality. , 1999, Rheumatology.

[91]  K. Flaherty,et al.  African-American race and antibodies to topoisomerase I are associated with increased severity of scleroderma lung disease. , 1998, Chest.

[92]  D. Brown,et al.  Scleroderma Lung Disease , 1997, European Respiratory Review.

[93]  E. Gabbay,et al.  Interstitial lung disease in recent onset rheumatoid arthritis. , 1997, American journal of respiratory and critical care medicine.

[94]  D. Schwartz,et al.  Rheumatoid arthritis lung disease. Determinants of radiographic and physiologic abnormalities. , 1996, Arthritis and rheumatism.

[95]  T. Medsger,et al.  Severe restrictive lung disease in systemic sclerosis. , 1994, Arthritis and rheumatism.

[96]  D. Hansell,et al.  Fibrosing alveolitis associated with systemic sclerosis has a better prognosis than lone cryptogenic fibrosing alveolitis. , 1994, American journal of respiratory and critical care medicine.

[97]  T. McLoud,et al.  Chest CT in patients with scleroderma: prevalence of asymptomatic esophageal dilatation and mediastinal lymphadenopathy. , 1993, AJR. American journal of roentgenology.

[98]  Christina J. Herold,et al.  Interstitial lung disease in progressive systemic sclerosis: high-resolution CT versus radiography. , 1990, Radiology.

[99]  S. Benjamin,et al.  Pulmonary disease in progressive systemic sclerosis. A complication of gastroesophageal reflux and occult aspiration? , 1989, Archives of internal medicine.

[100]  C. Carrington,et al.  Lung biopsy in rheumatoid arthritis. , 1985, The American review of respiratory disease.

[101]  T. Kurita,et al.  The efficacy of tacrolimus in patients with interstitial lung diseases complicated with polymyositis or dermatomyositis. , 2015, Rheumatology.

[102]  Takeshi Johkoh,et al.  American Thoracic Society Documents An Official ATS / ERS / JRS / ALAT Statement : Idiopathic Pulmonary Fibrosis : Evidence-based Guidelines for Diagnosis and Management , 2011 .

[103]  Jeffrey J. Swigris,et al.  Doença pulmonar intersticial relacionada a miosite e a síndrome antissintetase , 2011 .

[104]  T. Colby,et al.  The major histopathologic pattern of pulmonary fibrosis in scleroderma is nonspecific interstitial pneumonia. , 2002, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.

[105]  M. Maniati,et al.  Idiopathic pulmonary fibrosis and pulmonary fibrosis in diffuse systemic sclerosis: two fibroses with different prognoses. , 1997, Respiration; international review of thoracic diseases.

[106]  S. Calvieri,et al.  Relationship between cutaneous and pulmonary involvement in systemic sclerosis. , 1997, The Journal of rheumatology.

[107]  M. Obana,et al.  Cause of death in 81 autopsied patients with rheumatoid arthritis. , 1994, The Journal of rheumatology.

[108]  M. Hakala,et al.  Poor prognosis in patients with rheumatoid arthritis hospitalized for interstitial lung fibrosis. , 1988, Chest.